We next determined the extent to which cholesterol efflux capacity was independently associated with HDL cholesterol, apoA-I and low-grade inflammation in all subjects combined, as well as in NGM, IGM and T2DM subjects, and in subjects with and without MetS separately. Here, APOA1 is linked to metabolic syndrome.